India’s Biocon Biologics agrees to buy Viatris biosimilar assets for up to $3.35B
Maks_Lab/iStock by way of Getty Photographs India's Biocon Biologics agreed to amass Viatris Inc.'s biosimilar ...
Read more
Maks_Lab/iStock by way of Getty Photographs India's Biocon Biologics agreed to amass Viatris Inc.'s biosimilar ...
Read more